Human Factor XIII congenital deficient plasma (severe <1%)

Frozen

Packaging options

6-PPD13C-S	Vial	Minimum 50 mL

Plasma from a human donor with congenital FXIII deficiency.

Description of the Human Factor XIII congenital deficient plasma (severe <1%)

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Advantages

Minimize test time.
Ready to use.

Informations

Factor XIII is synthesized by the liver.
Activated by thrombin, FXIII intervenes in the final phase of fibrinoformation to stabilize the fibrin clot by forming covalent bonds in the fibrin polymer.

product sheet

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

Human Factor XIII congenital deficient plasma (severe <1%)

Price list, safety data sheets and notices are accessible to our registered customers.

My personal Space

Nouveau client

Human Factor XIII congenital deficient plasma (severe <1%)

Price list, safety data sheets and notices are accessible to our registered customers.

Associated products

Human Factor II congenital deficient plasma >5%

Human Factor IX congenital deficient plasma (severe <1%)

Human Factor IX congenital deficient plasma >5%

Human Factor V congenital deficient plasma (severe <1%)

Human Factor V congenital deficient plasma >5%

Human Factor VII congenital deficient plasma (severe <1%)

Human Factor VII congenital deficient plasma >5%

Human Factor VIII congenital deficient plasma (severe <1%)

Human Factor VIII congenital deficient plasma >5%

Human Factor X congenital deficient plasma (severe <1%)

Human Factor X congenital deficient plasma >5%

Human Factor XI congenital deficient plasma (severe <1%)

Human Factor XI congenital deficient plasma >5%

Human Factor XII congenital deficicent plasma >5%

Human Factor XII congenital deficient plasma (severe <1%)

Human Factor XIII congenital deficient plasma >5%